Publications

Personal Research Metrics*:

284 scientific papers published
H-index 62, 78,167 citations, i10-index 117
*accessed 10 April 2020 from Google Scholar

Section Editor (Epidemiology) for Eye (journal of Royal College of Ophthalmologists)

Invited reviewer for 10 other journals (including British Medical Journal, Acta Scandinavica Ophthalmologica, Ophthalmic Epidemiology, Investigative Ophthalmology and Visual Science, Eye, American Journal of Ophthalmology, Public Library of Science (Academic Editor), British Journal of Ophthalmology, Ophthalmic Physiol Opt

Invited RESEARCH GRANTS reviewer for Fight for Sight UK and Wellcome Foundation.

Grant funding in excess of £4million for NIHR clinical trials and non-NIHR research studies.

Grant funding in excess of £1.9 million for non-commercial investigator-initiated research studies

Grant funding in excess of £1.9 million for non-commercial investigator-initiated research studies

Journals articles:

  • Bourne, Rupert R.A. Vision 2020: where are we? Curr Opin Ophthalmol. 2019 Dec 31
  • Leanne McDonald, Paula Turnbull, Lydia Chang, David P. Crabb. Taking the strain? Impact of glaucoma on patients’ informal caregivers. Eye 2019. December.
  • Leveziel N, Marillet S, Dufour Q, Lichtwitz O, Bentaleb Y, Pelen F, Ingrand P, Bourne R. Prevalence of macular complications related to myopia – Results of a multicenter evaluation of myopic patients in eye clinics in France. Acta Ophthalmol. 2020 e245-251.
  • Cheng CY, Wang N, Wong TY, Congdon N, He M, Wang YX, Braithwaite T, Casson RJ, Cicinelli MV, Das A, Flaxman SR, Jonas JB, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Bourne RRA; Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019 Aug 28.
  • Fraenkel, Lee G, Vincent SJ, Vincent RA, Bourne RRA, Shah P. Lessons Learned from the Development and Implementation of a Glaucoma Patient-reported Outcome and Experience Measure (POEM). BMC Ophthalmology 2019: 192
  • Wozniak D1,2, Bourne R2,3,4, Peretz G4, Kean J4, Willshire C4, Harun S4, Villar S5,6, Chiu YD5, Smith I1. Obstructive Sleep Apnoea in Patients With Primary-Open Angle Glaucoma: No Role for a Screening Program. J Glaucoma. 2019 May 31
  • Nangia V#1, Jonas JB#2, George R3, Lingam V3, Ellwein L4, Cicinelli MV5, Das A6, Flaxman SR7, Keeffe JE8, Kempen JH9,10, Leasher J11, Limburg H12, Naidoo K13, Pesudovs K14, Resnikoff S15, Silvester AJ16, Tahhan N15, Taylor HR17, Wong TY18, Bourne RRA19; Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia. Br J Ophthalmol. 2019 Jul;103(7):871-877
  • Braithwaite T, Bailey H, Bartholomew D, Saei A, Pesudovs K, Ramsewak SS, Bourne R, Gray A. Impact of Vision Loss on Health-Related Quality of Life in Trinidad and Tobago. Ophthalmology. 2019 Jul;126(7):1055-1058.
  • Braithwaite T, Verlander NQ, Peto T, Bartholomew D, Deomansingh F, Bridgemohan P, Saei A, Sharma S, Singh D, Ramsewak SS, Bourne RRA. National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years. Br J Ophthalmol. 2019 Mar 26.
  • McDonald L, Boodhna T, Ajtony C, Turnbull P, Bourne RRA, Crabb DP. Illness perceptions in people newly diagnosed with glaucoma and ocular hypertension. Br J Ophthalmol. 2019 May 11.
  • Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Anurag Garg, Victoria Vickerstaff, Rachael Hunter, Gareth Ambler, Catey Bunce, Richard Wormald, Neil Nathwani, Keith Barton, Gary Rubin, Marta Buszewicz; on behalf of the LiGHT Trial Study Group*. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet March 2019.
  • Rupert R. A. Bourne, FRCOphth, MD1,2; Jost B. Jonas, MD3; Serge Resnikoff, MD, PhD4. Looking Within Rather Than Between Countries to Understand the Risk Factors for Vision Impairment. JAMA Ophthalmol. 2019;137(2):158-159.
  • Dawson SR1, Linton E2, Beicher K3, Gale R4,5, Patel P6, Ghanchi F7, Beresford MW8,9, Poustie V8, Chakravarthy U10, Bourne RRA11,12; NIHR Ophthalmology Specialty Group. Ophthalmology research in the UK’s National Health Service: the structure and performance of the NIHR’s Ophthalmology research portfolio. Eye (Lond). 2018 Nov 20.
  • Balal S, Udoh A, Pappas Y, et al. The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomized controlled trial. BMJ Open 2018.
  • Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia. Nangia V, Jonas JB, George R, Lingam V, Ellwein L, Cicinelli MV, Das A, Flaxman SR, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA; Vision Loss Expert Group of the Global Burden of Disease Study. Br J Ophthalmol. 2018 Nov 8
  • Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections. Keeffe JE, Casson RJ, Pesudovs K, Taylor HR, Cicinelli MV, Das A, Flaxman SR, Jonas JB, Kempen JH, Leasher J, Limburg H, Naidoo K, Silvester AJ, Stevens GA, Tahhan N, Wong TY, Resnikoff S, Bourne RRA. Br J Ophthalmol. 2018 Sep 12.
  • Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. Leasher JL, Braithwaite T, Furtado JM, Flaxman SR, Lansingh VC, Silva JC, Resnikoff S, Taylor HR, Bourne RRA; Vision Loss Expert Group of the Global Burden of Disease Study. Br J Ophthalmol. 2018 Sep 12.
  • Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections. Kahloun R, Khairallah M, Resnikoff S, Cicinelli MV, Flaxman SR, Das A, Jonas JB, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA. Br J Ophthalmol. 2018 Sep 12.
  • Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, Friedman DS, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Peto T, Saadine J, Silvester AJ, Tahhan N, Taylor HR, Varma R, Wong TY, Resnikoff S; Vision Loss Expert Group of the Global Burden of Disease Study. Br J Ophthalmol. 2018 May;102(5):575-585
  • Zhekov I, Pardhan S, Bourne RR. Ocular coherence tomography-measured changes over time in anterior chamber angle and diurnal intraocular pressure after laser iridotomy: IMPACT study. Clin Exp Ophthalmol. 2018 Nov;46(8):895-902
  • Manuscript ID bmjopen-2018-026770 – The Feasibility of Fingerprick Autologous Blood (FAB) As a Novel Treatment for Severe Dry Eye Disease (DED): Protocol for a Randomised Controlled Trial, Accepted by BMJ Open 20.9.18
  • Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, Friedman DS, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Peto T, Saadine J, Silvester AJ, Tahhan N, Taylor HR, Varma R, Wong TY, Resnikoff S; Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018 May;102(5):575-585
  • Konstantakopoulou E, Gazzard G, Vickerstaff V, Jiang Y, Nathwani N, Hunter R, Ambler G, Bunce C; LiGHT Trial Study Group. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics. Br J Ophthalmol. 2018 May;102(5):599-603.
  • Gazzard G, Konstantakopoulou E, Garway-Heath D, Barton K, Wormald R, Morris S, Hunter R, Rubin G, Buszewicz M, Ambler G, Bunce C; LiGHT Trial Study Group. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2018 May;102(5):593-598
  • Vickerstaff V, Ambler G, Bunce C, Xing W, Gazzard G; LiGHT Trial Study Group. Erratum to Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial. Trials. 2017 Jul 11;18(1):318.
  • Vickerstaff V, Ambler G, Bunce C, Xing W, Gazzard G; LiGHT Trial Study Group. Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial. Trials. 2015 Nov 11;16:517.
  • Foreman et al. Prevalence and Causes of Unilateral Vision Impairment and Unilateral Blindness in Australia. JAMA Ophthalmology Jan2018.
  • Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234.
  • Ackland P, Resnikoff S, Bourne R. World blindness and visual impairment: despite many successes, the problem is growing. Community Eye Health Journal 2017;30(100):71-73.
  • Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Authors´reply. Reply to the letter-to-the-editor, written by „Salem CB, Fathallah N, Zayani H. Glaucoma“, referring to the article „Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet 2017;390:2183–2193.“ Lancet 2018;391:740.
  • Delcourt et al. The decreasing prevalence of non-refractive visual impairment in older Europeans: a meta-analysis of published and unpublished data. Ophthalmology Feb 2018.
  • Claudia Becker1, Cornelia Schneider1,2, Samuel Aballéa3, Rupert Bourne4, Clare Bailey5, Susan Jick6, Christoph Meier1. Cataract in patients with diabetes mellitus incidence rates in the UK and risk factorsCataract in patients with diabetes mellitus—incidence rates in the UK and risk factors. Eye Jan 2018.
  • Braithwaite T, Winford B, Bailey H, Bridgemohan P, Bartholomew D, Singh D, Sharma, Sharma R, Silva JC, Gray A, Ramsewak SS, Bourne RRA. Health system dynamics analysis of eyecare services in Trinidad and Tobago and progress towards Vision 2020 Goals. Health Policy and Planning. 30 October 2017
  • GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1260-1344.
  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017 Sep 16;390(10100):1211-1259.
  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. GBD 2016 Causes of Death Collaborators. Lancet. 2017 Sep 16;390(10100):1151-1210.
  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. GBD 2016 Mortality Collaborators. Lancet. 2017 Sep 16;390(10100):1084-1150.
  • Konstantakopoulou E, Gazzard G, Vickerstaff V, Jiang Y, Nathwani N, Hunter R, Ambler G, Bunce C; LiGHT Trial Study Group. The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics. Br J Ophthalmol. 2017 Oct 5
  • Gazzard G, Konstantakopoulou E, Garway-Heath D, Barton K, Wormald R, Morris S, Hunter R, Rubin G, Buszewicz M, Ambler G, Bunce C; LiGHT Trial Study Group. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2017 Sep 13.
  • Bourne RRA1, Flaxman SR2, Braithwaite T3, Cicinelli MV4, Das A5, Jonas JB6, Keeffe J7, Kempen JH8, Leasher J9, Limburg H10, Naidoo K11, Pesudovs K12, Resnikoff S13, Silvester A14, Stevens GA15, Tahhan N13, Wong TY16, Taylor HR17; Vision Loss Expert Group. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017 Aug 2.
  • Virgili G, Michelessi M, Cook J, Boachie C, Burr J, Banister K, Garway-Heath DF, Bourne RRA, Asorey Garcia A, Ramsay CR, Azuara-Blanco A. Diagnostic accuracy of optical coherence tomography for diagnosing glaucoma: secondary analyses of the GATE study. Br J Ophthalmol. 2017 Aug 30.
  • Chakravarthy U, Biundo E, Saka RO, Fasser C, Bourne R, Little JA. The Economic Impact of Blindness in Europe.Ophthalmic Epidemiol. 2017 Jun 30:1-9.
  • Wang B1,2, Congdon N3,4,5, Bourne R6, Li Y7, Cao K1, Zhao A1, Yusufu M1, Dong W8, Zhou M8, Wang N1,2. Burden of vision loss associated with eye disease in China 1990–2020: findings from the Global Burden of Disease Study 2015. Br J Ophthalmol. 2017 Jun 12.
  • The prevalence and causes of vision loss in Indigenous and non-Indigenous Australians: The National Eye Health Survey. Edward Keel, Peter Van Wijngaarden, Sukhpal Singh Sandhu, Brian Ang, Jennifer Chen Chia Fan Gaskin, Jonathan Crowston, Hugh Taylor. Ophthalmology, In Press 2017.
  • Jost B. Jonas, Tin Aung, Rupert R. Bourne, Alain M. Bron, Robert Ritch, Songhomitra Panda-Jonas. Glaucoma. Lancet 2017;390(10108):2183–2193
  • Katie Banister, Craig Ramsay, Augusto Azuara-Blanco, Jonathan Cook, Charles Boachie, Jennifer Burr, Manjula Kumarasamy, Rupert Bourne. Challenges in dealing with suspected disease in glaucoma diagnostic accuracy studies. Diagnostic and Prognostic Research 2017, 1(Suppl 1):7.
  • Pardhan S, Scarfe A, Bourne R, Timmis M. A Comparison of Reach-to-Grasp and Transport-to-Place Performance in Participants with Age-related Macular Degeneration and Glaucoma. . Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1560-1569.
  • Braithwaite T, Verlander NQ, Bartholomew D, Bridgemohan P, McNally K, Roach A, Sharma S, Singh D, Pesudovs K, Teelucksingh S, Carrington C, Ramsewak S, Bourne R; NESTT Study Group. The National Eye Survey of Trinidad and Tobago (NESTT): Rationale, Objectives and Methodology. Ophthalmic Epidemiol. 2017 Apr;24(2):116-129.
  • Bourne RR, Zhekov I, Pardhan S. Temporal ocular coherence tomography-measured changes in anterior chamber angle and diurnal intraocular pressure after laser iridoplasty: IMPACT study. Br J Ophthalmol. 2016 Dec 7 [Epub ahead of print].
  • Braithwaite T, Taylor H, Bourne R, Keeffe J, Pesudovs K. Does blindness count? Disability weights for vision loss. Clin Exp Ophthalmol. 2016 Nov 11
  • Bourne RR1, Taylor HR2, Flaxman SR3, Keeffe J4, Leasher J5, Naidoo K6, Pesudovs K7, White RA8, Wong TY9, Resnikoff S10, Jonas JB11; Vision Loss Expert Group of the Global Burden of Disease Study. Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 – 2010: A Meta-Analysis. PLoS One. 2016 Oct 20;11(10):e0162229. doi: 10.1371/journal.pone.0162229. eCollection 2016.
  • GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1725-1774
  • GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724
  • GBD 2015 DALYs and HALE Collaborators.Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603-1658
  • GBD 2015 Mortality and Causes of Death Collaborators.Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544
  • GBD 2015 SDG Collaborators.Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1813-1850
  • Naidoo KS, Leasher J, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Limburg H, Pesudovs K, Price H, White RA, Wong TY, Taylor HR, Resnikoff S; Vision Loss Expert Group of the Global Burden of Disease Study. Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990-2010. Optom Vis Sci. 2016 Mar;93(3):227-34
  • Allana Roach, Tasanee Braithwaite, Christine Carrington, Elysse Marcellin, Subash Sharma, Aroon Hingorani, Juan Pablo Casas, Michael A. Hauser, R. Rand Allingham, Samuel S. Ramsewak, Rupert Bourne. Addressing ethical challenges in the Genetics Substudy of the National Eye Survey of Trinidad and Tobago (GSNESTT). Appl Transl Genom. 2016 May 12;9:6-14.
  • Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A meta-analysis from 1990-2010. Janet Leasher, OD, MPH (1)*, Rupert R. A. Bourne, FRCOphth MD(2)*, Seth R. Flaxman, BA (3), Jost B. Jonas, MD*(4), Jill Keeffe, PhD (5), Kovin Naidoo, OD MPH (6), Konrad Pesudovs, PhD (7), Holly Price, BSc PhD (2), Richard A. White, PhD(8), Tien Y. Wong, MD, PhD (9), Serge Resnikoff, MD, PhD**(10), Hugh R. Taylor, AC MD** (11), on behalf of the Vision Loss Expert Group§ of the Global Burden of Disease Study. Diabetes Care 2016: 39:1643-1649.
  • Bourne R1, Johnson C, Lawrenson J, Bui BV. Glaucoma: basic science and clinical translation. Ophthalmic Physiol Opt. 2015 Mar;35(2):111-3. doi: 10.1111/opo.12203.
  • Azuara-Blanco A, Banister K, Boachie C, McMeekin P, Gray J, Burr J, Bourne R, Garway-Heath D, Batterbury M, Hernandez R, McPherson G, Ramsay C, Cook J. Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study). Health Technology Assessment 2016 Feb: 20(8).
  • Katie Banister1, Charles Boachie2, Rupert Bourne3, Jonathan Cook4, Jennifer M Burr5, Craig Ramsay1, David Garway-Heath6, Joanne Gray7, Peter McMeekin7, Rodolfo Hernández,8 Augusto Azuara-Blanco9. Can automated imaging with HRT for disc and GDx-ECC and Spectralis OCT for retinal nerve fiber layer analysis aid glaucoma detection? Ophthalmology. 2016 May;123(5):930-8
  • Azuara-Blanco A, Banister K, Boachie C, McMeekin P, Gray J, Burr J, Bourne R, Garway-Heath D, Batterbury M, Hernandez R, McPherson G, Ramsay C, Cook J. Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study). Health Technology Assessment 2016 Feb: 20(8).
  • Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010. Khairallah M, Kahloun R, Bourne R, Limburg H, Flaxman SR, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY, Resnikoff S, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study. Invest Ophthalmol Vis Sci. 2015 Oct 1;56(11):6762-9.
  • GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71.
  • Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800.
  • GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28;386(10009):2145-91.
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. GBD 2013 Risk Factors Collaborators. Lancet. 2015 Nov 28;386(10009):2145-91.
  • Brien A Holden,a Nina Tahhan,b Monica Jong,b David A Wilson,b Timothy R Fricke,b Rupert Bournec & Serge Resnikoff.. Towards better estimates of uncorrected presbyopia. Editorial. Bull World Health Organ 2015;93:667
  • Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Newton JN, Briggs AD, Murray CJ et al with R Bourne as co-author. Lancet. 2015 Dec 5;386(10010):2257-74.
  • Ratnarajan G, Kean J, French K, Parker M, Bourne R. The false negative rate and the role for virtual review in a nationally evaluated glaucoma referral refinement scheme. Ophthalmic Physiol Opt. 2015 Sep;35(5):577-81.
  • Sanchez-Parra L, Pardhan S, Buckley RJ, Parker M, Bourne RR. Diurnal Intraocular Pressure and the Relationship With Swept-Source OCT-Derived Anterior Chamber Dimensions in Angle Closure: The IMPACT Study. Invest Ophthalmol Vis Sci. 2015 May 1;56(5):2943-9.
  • Zheng Li, R Rand Allingham, Masakazu Nakano et al, with R Bourne as co-author. A common variant near TGFBR3 is associated with primary open angle Glaucoma. Hum Mol Genet. 2015 Jul 1;24(13):3880-92
  • David F Garway-Heath, David P Crabb, Catey Bunce, Gerassimos Lascaratos, Francesca Amalfi tano, Nitin Anand, Augusto Azuara-Blanco, Rupert R Bourne, David C Broadway, Ian A Cunliff e, Jeremy P Diamond, Scott G Fraser, Tuan A Ho, Keith R Martin, Andrew I McNaught, Anil Negi, Krishna Patel, Richard A Russell, Ameet Shah, Paul G Spry, Katsuyoshi Suzuki, Edward T White, Richard P Wormald, Wen Xing, Thierry G Zeyen. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet December 2014.
  • Ratnarajan G, Somner J, Coombes E, Jones A, Bourne R. The Equity Profile of an Enhanced Optometry scheme. Ophthalmic Physiol Opt. 2015. Mar;35(2):243-4.
  • Ratnarajan G1, Somner J1, Coombes E2, Jones A2, Bourne R1. Awareness of sight-testing entitlements in patients referred for suspected glaucoma. Eye (Lond). 2014 Apr;28(4):504-5. doi: 10.1038/eye.2014.9. Epub 2014 Feb 7.
  • Keenan J1, Shahid H, Bourne RR, White AJ, Martin KR. Cambridge community Optometry Glaucoma Scheme. Clin Experiment Ophthalmol. 2014 Jul 28. doi: 10.1111/ceo.12398. [Epub ahead of print]
  • Jonas JB, Bourne RR, White RA, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, Wong TY, Resnikoff S, Taylor HR, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Visual impairment and blindness due to macular diseases globally: A systematic review and meta-analysis. Am J Ophthalmol. 2014 Oct;158(4):808-15
  • Bourne RRA, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Parodi M, Pesudovs K, Price H, White RA, Wong TY, Resnikoff S, Taylor HR, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol 2014; 98:629-638
  • Khairallah M, Kahloun R, Flaxman SR, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY, Stevens GA*, Resnikoff S*, Taylor HR*, Bourne RR*, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010. Br J Ophthalmol 2014; 98:605-611
  • Naidoo K, Gichuhi S, Basáñez MG, Flaxman SR, Jonas JB, Keeffe J, Leasher J, Pesudovs K, Price H, Smith J, Turner HC, White RA, Wong TY, Resnikoff S, Taylor HR, Bourne RR, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Sub-Saharan Africa: 1990-2010. Br J Ophthalmol 2014; 98:612-618
  • Leasher JL, Lansingh V, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, Pesudovs K, Price H, Silva JC, White RA, Wong TY, Resnikoff S, Taylor HR, Bourne RR; on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010. Br J Ophthalmol 2014; 98:619-628
  • Jonas JB, George R, Asokan R, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, Vijaya L, White RA, Wong TY, Resnikoff S, Taylor HR, Bourne RR, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Central and South Asia: 1990-2010. Br J Ophthalmol 2014; 98:592-598.
  • Keeffe J, Taylor HR, Pesudovs K, Flaxman SR, Jonas JB, Leasher J, Naidoo K, Price H, White RA, Wong TY, Stevens GA, Resnikoff S, Bourne RR, on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Southeast Asia and Oceania: 1990-2010. Br J Ophthalmol 2014;98:586-591
  • Wong TY, Zheng Y, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, White RA, Resnikoff S, Taylor HR, Bourne RR; on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in East Asia: 1990-2010. Br J Ophthalmol 2014; 98:599-604
  • Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR; on behalf of the Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013 Dec;1(6):e339-e349.
  • Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H, Coffeng LE, Fèvre EM, Fürst T, Halasa YA, Jasrasaria R, Johns NE, Keiser J, King CH, Lozano R, Murdoch ME, O’Hanlon S, Pion SD, Pullan RL, Ramaiah KD, Roberts T, Shepard DS, Smith JL, Stolk WA, Undurraga EA, Utzinger J, Wang M, Murray CJ, Naghavi M. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865. doi: 10.1371/journal.pntd.0002865. eCollection 2014 Jul.
  • McGregor, Somner J, Bourne et al. “Social media use by patients with glaucoma: What can we learn?” Ophth Physiol Optics 2014: 34: 46-52.
  • John EA Somner, Freda Sii, Rupert Bourne, Vinette Cross, Peter Shah. What do patients with glaucoma think about personal health records? Ophth Physiol Opt 2013:33:627-633.
  • Stevens G, White R, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor H, Bourne R. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology 2013;120(12):2377-84.
  • Ratnarajan G, Newsom W, Vernon SA, Fenerty C, Henson D, Spencer F, Wang Y, Harper R, McNaught A, Collins L, Parker M, Lawrenson J, Hudson R, Khaw PT, Wormald R, Garway-Heath D, Bourne R. The effectiveness of schemes that refine referrals between primary and secondary care–the UK experience with glaucoma referrals: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways Project. BMJ Open. 2013 Jul 21;3(7).
  • Christopher JL Murray, et al. with R Bourne as co-author. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013: March 5- E pub.
  • Christopher J L Murray, Michael A Richards, John N Newton, Kevin A Fenton, H Ross Anderson, Charles Atkinson, Derrick Bennett, Eduardo Bernabé, Hannah Blencowe, Rupert Bourne, Tasanee Braithwaite, Carol Brayne, Nigel G Bruce, Traolach S Brugha, Peter Burney, Mukesh Dherani, Helen Dolk, Karen Edmond Majid Ezzati, Abraham D Flaxman, Tom D Fleming, Greg Freedman, David Gunnell, Roderick J Hay, Sally J Hutchings, Summer Lockett Ohno, Rafael Lozano, Ronan A Lyons, Wagner Marcenes, Mohsen Naghavi, Charles R Newton, Neil Pearce, Dan Pope, Lesley Rushton, Joshua A Salomon, Kenji Shibuya, Theo Vos, Haidong Wang, Hywel C Williams,Anthony D Woolf, Alan D Lopez, Adrian Davis. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013: March 5- E pub.
  • Bourne R, Gale R. The Ophthalmology Specialty Group and the National Institute for Health Research- the first 6 years. Eye 2013; 27:457-60.
  • Gokulan Ratnarajan, Wendy Newsom, Karen French, Jane Kean, Lydia Chang, Mike Parker, David F Garway-Heath, Rupert RA Bourne. The impact of glaucoma referral refinement criteria on referral to, and first-visit discharge rates from, the hospital eye service: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways project. Ophthalmic Physiol Opt 2013 (accepted. doi: 10.1111/opo.12029).
  • Lim SS, Vos T, Flaxman AD, et al. with R Bourne as co-author. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2224-60.
  • Murray CJ, Vos T, Lozano R, et al. with R Bourne as co-author. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2197-223.
  • Vos T, Flaxman AD, et al, with R Bourne as co-author. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2163-96.
  • Salomon JA, Vos T, Hogan DR, with R Bourne as co-author. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2129-43.
  • Gokulan Ratnarajan, Wendy Newsom, Karen French, Jane Kean, Lydia Chang, Mike Parker, David F Garway-Heath, Rupert Richard Alexander Bourne. The effect of changes in referral behaviour following NICE guideline publication on agreement of examination findings between professionals in an established glaucoma referral refinement pathway: The Health Innovation & Education Cluster (HIEC) Glaucoma Pathways project. Br J Ophthalmol 2013;97(2):210-4.
  • Rupert Bourne, Holly Price, Hugh Taylor, et al. New Systematic Review Methodology for Visual Impairment and Blindness for the 2010 Global Burden of Disease Study. Ophth Epidemiol 2013;20(1):33-9.
  • The United Kingdom Glaucoma Treatment Study: a multicentre, randomized,placebo-controlled clinical trial. Design and methodology. Ophthalmology 2012 (accepted). Co-author. Manuscript 2012-427R1.
  • Somner JE, Sii F, Bourne RR, Cross V, Burr JM, Shah P. Moving from PROMs to POEMs for glaucoma care – a qualitative scoping exercise. Invest Ophthalmol Vis Sci. 2012 Aug 31;53(9):5940-7.
  • McCormick et al. Retinal vessel tortuosity in response to hypobaric hypoxia. High Altitude Medicine and Biology, accepted 2012.
  • Bourne R, Price H, Stevens G. Global Burden of Visual Impairment and Blindness. Arch Ophthalmol. 2012;130(5):645-647.
  • Mandalos A, Bourne R, French K, Newsom W, Chang L. Shared care of patients with ocular hypertension in the Community and Hospital Allied Network Glaucoma Evaluation Scheme (CHANGES). Eye (Lond). 2012 Jan 6. doi: 10.1038/eye.2011.350.
  • Bourne R et al. The national eye survey of trinidad and tobago (NESTT): Rationale and methodology. West Indian Medical Journal. 2012. 61:14.
  • Landers J, Martin K, Sarkies N, Bourne R, Watson P. A Twenty-Year Follow-up Study of Trabeculectomy: Risk Factors and Outcomes. Ophthalmology. 2011 Dec 23.
  • Bourne RR. Eye (Lond). Ethnicity and ocular imaging. 2011 Mar;25(3):297-300. Epub 2010 Dec 17.
  • Bourne RR, French KA, Chang L, Borman AD, Hingorani M, Newsom WD. Can a community optometrist-based referral refinement scheme reduce false-positive glaucoma hospital referrals without compromising quality of care? The community and hospital allied network glaucoma evaluation scheme (CHANGES). Eye (Lond). 2010 May;24(5):881-7.
  • Gibbons H, Bourne RR. Extending a nurse practitioner’s role to include the undertaking of advanced procedures.. Nurs Times. 2009 Oct 20-26;105(41):24-6.
  • Shah SP, Jadoon MZ, Dineen B, Bourne RR, Johnson GJ, Gilbert CE, Khan MD. Refractive errors in the adult pakistani population: the national blindness and visual impairment survey. Ophthalmic Epidemiol. 2008 May-Jun;15(3):183-90.
  • Shah SP, Minto H, Jadoon MZ, Bourne RR, Dineen B, Gilbert CE, Khan MD; Pakistan National Eye Survey Study Group. Prevalence and causes of functional low vision and implications for services: the Pakistan National Blindness and Visual Impairment Survey. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):887-93.
  • Bourne RR, Foster PJ, Bunce C, Peto T, Hitchings RA, Khaw PT, Seah SK, Garway-Heath DF. The morphology of the optic nerve head in the Singaporean Chinese population (the Tanjong Pagar study): part 2–Biometric and systemic associations. Br J Ophthalmol. 2008 Mar;92(3):310-4.
  • Bourne RR, Foster PJ, Bunce C, Peto T, Hitchings RA, Khaw PT, Seah SK, Garway-Heath DF. The morphology of the optic nerve head in the Singaporean Chinese population (the Tanjong Pagar study): part 1–Optic nerve head morphology. Br J Ophthalmol. 2008 Mar;92(3):303-9.
  • Taylor AE, Shah SP, Gilbert CE, Jadoon MZ, Bourne RR, Dineen B, Johnson GJ, Khan MD; Pakistan National Eye Survey Study Group. Visual function and quality of life among visually impaired and cataract operated adults. The Pakistan National Blindness and Visual Impairment Survey. Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):242-9.
  • Shah SP, Dineen B, Jadoon Z, Bourne R, Khan MA, Johnson GJ, De Stavola B, Gilbert C, Khan MD. Lens opacities in adults in Pakistan: prevalence and risk factors. Ophthalmic Epidemiol. 2007 Nov-Dec;14(6):381-9.
  • Gilbert CE, Shah SP, Jadoon MZ, Bourne R, Dineen B, Khan MA, Johnson GJ, Khan MD; Pakistan National Eye Survey Study Group. Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey. BMJ. 2008 Jan 5;336(7634):29-32. Epub 2007 Dec 17.
  • Bourne RR, Jahanbakhsh K, Boden C, Zangwill LM, Hoffmann EM, Medeiros FA, Weinreb RN, Sample PA. Reproducibility of visual field end point criteria for standard automated perimetry, full-threshold, and Swedish interactive thresholding algorithm strategies: diagnostic innovations in glaucoma study. Am J Ophthalmol. 2007 Dec;144(6):908-913. Epub 2007 Oct 24.
  • Uncorrected refractive error and presbyopia: accommodating the unmet need. Br J Ophthalmol. 2007 Jul;91(7):848-50.
  • Jadoon Z, Shah SP, Bourne R, Dineen B, Khan MA, Gilbert CE, Foster A, Khan MD; Pakistan National Eye Survey Study Group. Cataract prevalence, cataract surgical coverage and barriers to uptake of cataract surgical services in Pakistan: the Pakistan National Blindness and Visual Impairment Survey. Br J Ophthalmol. 2007 Oct;91(10):1269-73.
  • Dineen B, Bourne RR, Jadoon Z, Shah SP, Khan MA, Foster A, Gilbert CE, Khan MD; Pakistan National Eye Survey Study Group. Causes of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment survey. Br J Ophthalmol. 2007 Aug;91(8):1005-10.
  • Bourne R, Dineen B, Jadoon Z, Lee PS, Khan A, Johnson GJ, Foster A, Khan D. Outcomes of cataract surgery in Pakistan: results from The Pakistan National Blindness and Visual Impairment Survey. Br J Ophthalmol. 2007 Apr;91(4):420-6.
  • Smith TS, Szetu J, Bourne RR. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu. Br J Ophthalmol. 2007 Apr;91(4):415-9.
  • Bourne RRA. The Optic Nerve Head in Glaucoma. J Community Eye Health 2006;19:12-13.
  • Ng D, Zangwill L, Racette L, Bowd C, Pasual J, Bourne R, Boden C, Weinreb R, Sample P. Agreement and Repeatability for Standard Automated Perimetry and Confocal Scanning Laser Ophthalmoscopy in the Diagnostic Innovations in Glaucoma Study. Am J Ophth 2006:142:381-386.
  • Jadoon MZ, Dineen B, Bourne RRA, Shah SP, Khan A, Johnson GJ, Gilbert CE, Khan MD. Prevalence of blindness and visual impairment in Pakistan: The Pakistan National Blindness and Visual Impairment Survey. Invest Ophthalmol Vis Sci 2006; 47(11):4749-55.
  • The Eye at Altitude. Daniel Morris, John Somner, Michael Donald, Ian McCormick, Rupert Bourne, Suber Huang, Peter Aspinall, Baljean Dhillon. Advances in Experimental Medicine & Biology. Vol. 588, p249-270.
  • Hoffmann EM, Boden C, Zangwill LM, Bourne RR, Weinreb RN, Sample PA. Inter-eye comparison of patterns of visual field loss in patients with glaucomatous optic neuropathy. Am J Ophthalmol. 2006 Apr;141(4):703-8.
  • Hoffmann EM, Medeiros FA, Sample PA, Boden C, Bowd C, Bourne RR, Zangwill LM, Weinreb RN. Relationship between patterns of visual field loss and retinal nerve fiber layer thickness measurements. Am J Ophthalmol. 2006 Mar;141(3):463-471.
  • Bowd C, Zangwill LM, Medeiros FA, Tavares IM, Hoffmann EM, Bourne RR, Sample PA, Weinreb RN. Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2889-95.
  • Robert E MacLaren, Mythili Natkunarajah, Yasmin Riaz, Rupert RA Bourne Marie Restori, Bruce DS Allan. Biometry accuracy with 30+ Diopter Intraocular Lenses: biometry in extreme hyperopia. Am J Ophthalmol. 2007 Jun;143(6):920-931.
  • Bourne R. Worldwide glaucoma through the looking glass. Br J Ophth. 2006 90:253-254.
  • Michael H. Goldbaum, Pamela A. Sample, Zuohua Zhang, Kwokleung Chan, Jiucang Hao, Te-Won Lee, Catherine Boden, Christopher Bowd, Rupert Bourne, Linda Zangwill, Terrence Sejnowski, David Spinak, Robert N. Weinreb. Using Unsupervised Learning with Independent Component Analysis to Identify Patterns of Glaucomatous Visual Field Defects. Invest Ophthalmol Vis Sci. 2005 46:3676-3683.
  • Esther M. Hoffmann, Christopher Bowd, Felipe A. Medeiros, Catherine Boden, Franz H. Grus, Rupert R. Bourne, Linda M. Zangwill, Robert N. Weinreb. Agreement among 3 Optical Imaging Methods for the Assessment of Optic Disc Topography. Ophthalmology 2005 112 (12):2149-56.
  • R Bourne, B Dineen, Z Jadoon, P Lee, A Khan, G Johnson, A Foster, D Khan, Pakistan National Eye Survey Study Group. The Pakistan National Blindness and Visual Impairment Survey—Research Design, Eye Examination Methodology and Results of the Pilot Study. Ophthalmic Epidemiology 2005 12:321-333.
  • RRA Bourne, FA Medeiros, C Bowd, K Jahanbakhsh, LM Zangwill, RN Weinreb. Comparability of Retinal Nerve Fiber Layer thickness measurements with Optical Coherence Tomography instruments. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1280-5.
  • RRA Bourne, BP Dineen, SM Ali, DM Noorul Huq, GJ Johnson. Correction of Refractive Error in the Adult Population of Bangladesh: Meeting the Unmet Need. Invest Ophthalmol Vis Sci. 2004; 45:410-417.
  • Bourne RRA, Minassian DC, Dart JKG, Rosen P, Kaushal S, Wingate N. The effect of cataract surgery on the corneal endothelium: phakoemulsification compared with extracapsular cataract surgery. Ophthalmology. 2004 Apr;111(4):679-85.
  • RRA Bourne, BP Dineen, SM Ali, DM Noorul Huq, GJ Johnson. Prevalence of Refractive Error in Bangladeshi Adults – results of the National Blindness and Low Vision Survey of Bangladesh. Ophthalmology. 2004; 111:1150-1160.
  • R R A Bourne, B P Dineen, S M Ali, D M N Huq, G J Johnson. The Outcomes of Cataract Surgery in Bangladesh- results from a population-based nationwide survey. Br J Ophthalmol; 87:813-819. 2003.
  • Bourne RRA, Sukudom P, Foster PJ, Tantisevi V, Jitapunkul S, Lee PS, Johnson GJ, Rojanapongpun P. The prevalence of glaucoma in Thailand: a population-based survey in Rom Klao district, Bangkok. Br J Ophthalmol 2003; 87: 1069-1074.
  • Dineen B, Bourne RRA, Ali SM, Huq DMN, Johnson GJ. Prevalence and causes of blindness and visual impairment in Bangladeshi adults – results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol 2003; 87:820-828.
  • Bourne RRA, Dineen B, Ali SM, Huq DMN, Johnson GJ. The National Blindness and Low Vision Prevalence Survey of Bangladesh – research design, eye examination methodology and results of the pilot study. Ophthalmic Epidemiology 2002: Vol 9:119-132.
  • Dineen B, Bourne RRA, Ali SM, Huq DMN, Johnson GJ. Prevalence and causes of blindness and visual impairment in Bangladeshi adults – results of the National Blindness and Low Vision Survey of Bangladesh. Trans. Ophthalmol Soc Bang 2002; 29 (2):101-111.
  • Bourne RRA, Rosser DA, Sukudom P, Dineen B, Laidlaw DAH, Johnson GJJ, Murdoch IE. Evaluating a new logMAR chart designed to improve visual acuity assessment in population- based surveys. Eye 2003; 17(6): 754-758.
  • Bourne RRA, Sorensen KE, Klauber A, Foster PJ, Johnson G, Alsbirk PHA. Glaucoma in East Greenlandic Inuit- a population-based survey in Ittoqqortoormiit (Scoresbysund) Acta Ophthalmol Scand. 2001 Oct;79(5):462-7. Entry in Health Research in Greenland- 1999 (Innussuk, Arctic Research Journal.
  • Bourne RRA, MacLaren RE, Paralukar M. Excellent visual outcome following perforating gunshot injury to the globe. J R Army Med Corps 2002;148: 144-147.
  • RRA Bourne, SJ Talks,AB Richards. Treatment of preretinal valsalva haemorrhages with Neodymium:YAG laser. Eye 1999 13:6.
  • R Bourne, C Karabatsas, HB Hoh, R Finlay. Acute glaucoma associated with iris naevus syndrome. Ophthalmologia 1997, 9:296-299.
  • HB Hoh, R Bourne, R Baer. Visual recovery following phacoemulsification using topical anaesthesia. J Cataract Refract Surg 1998 Oct; 24(10): 1385-9.
  • Bourne RR, Ivanov VA, McKenzie SA. Sir John McNee bequest summary of a report on a period of elective study immunzation rates in Moscow preschool children. Trans Med Soc Lond. 1993-94; 110: 119-21.
  • Bourne RRA, MacLaren RE. Intracranial plasmacytoma masquerading as Gradenigo’s Syndrome. Br J Ophthalmol 1998; 82:456.
  • Bourne RRA, Dolin PJ, Mtanda AT, Plant GT, Mohamed AA. Epidemic optic neuropathy in primary school children in Dar es Salaam, Tanzania. Br J Ophthalmol 1998; 82: 232-234.
  • Bourne RRA, Greenwald S. The application of histomorphometric image analysis to the quantification of aortic scleroprotein and smooth muscle content. J Pathology 1993; 169: 163a.
  • Bourne RRA, Ivanov V, McKenzie S. Vaccination rates in Moscovite children. Lancet 1994; 344: 1366.

Books:

  1. Glaucoma: A Brain Disease. Author of Chapter: Epidemiological burden of blindness and visual disability in glaucomatous patients. Published 2018.
  2. ESASO Course Series Vol. 008: 446132. 2016. Author of Chapter: Imaging for Glaucoma Detection and Progression. Published by Karger
  3. World Glaucoma Association consensus series: IOP, Medical Treatment of Glaucoma, Diagnosis of Glaucoma
  4. Topics & Trends: Practicalities of Screening for Glaucoma
  5. Scanning Laser Imaging in Atlas of Glaucoma, 2nd Edition. Choplin, N.T. & Lundy, D.C. Eds. Authors: C Bowd, LM, Zangwill, RRA Bourne, RN Weinreb. 2006.
  6. The Eye at Altitude. Daniel Morris, John Somner, Michael Donald, Ian McCormick, Rupert Bourne, Suber Huang, Peter Aspinall, Baljean Dhillon. Advances in Experimental Medicine & Biology. Vol. 588, p249-270.
  7. Wolff’s Anatomy of the Eye and Orbit. AJ Bron, RC Tripathi, BJ Tripathi. Contributed a section on racial differences in optic disc morphology.
  8. Royal Geographical Society Expedition Medicine 2002, 2nd Edition & now 3rd Edition. Profile Books, London. Contributed the ophthalmology perspective.